Dr. Joseph M. Nussbaum, MD

Dr. Nussbaum practices at CHA Hollywood Presbyterian Medical Center in Los Angeles, California, part of CHA Health Systems.

Dr. Nussbaum's NPI, 1922033463, was assigned on July 12, 2006. Dr. Nussbaum graduated from Universidad Autonoma de Guadalajara in 1981. Dr. Nussbaum holds California license F46586.

Dr. Nussbaum's primary practice is CHA Hollywood Presbyterian Medical Center, at 1300 N Vermont Ave, Los Angeles, CA 90027 in Los Angeles County. The practice phone is (213) 413-3000.

Dr. Nussbaum's primary practice is CHA Hollywood Presbyterian Medical Center in Los Angeles, California, part of CHA Health Systems. Dr. Nussbaum is also affiliated with Los Angeles General Medical Center. The medical group on file is Optum - Downtown Los Angeles. Dmand AI also links Dr. Nussbaum to 2 more hospitals, 2 group practices and clinics, 2 medical groups and 1 breast imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nussbaum practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Nussbaum's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Nussbaum is board certified in infectious disease by the American Board of Internal Medicine. Dr. Nussbaum is licensed in California.

Dmand AI lists hiv/aids, joint or bone infection and shingles among the conditions Dr. Nussbaum treats.

CMS data shows 905 Medicare services from Dr. Nussbaum across 3 procedure codes in 2024, for 348 Medicare patients. Medicare paid $71,685 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 348 Medicare patients who saw Dr. Nussbaum in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 95% are also on Medicaid. Their average risk score is 3.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nussbaum's median patient age at 60, with 40% women.

In 2024, Dr. Nussbaum wrote 1,561 Medicare Part D claims for 114 patients. 55% of them were for generic drugs. CMS names the drug for 1,329 of them, across 44 drugs with 11 or more claims each, at $2,025,070 in total drug cost. In 2023, CMS named 1,633 claims across 47 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Nussbaum for performance year 2024, reported as part of a group. Dr. Nussbaum accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Nussbaum. The most frequent topics are Acquired Immunodeficiency Syndrome, Drug Therapy, Combination and Administration, Oral. Dr. Nussbaum has published most often in Ann Intern Med. Dr. Nussbaum's most frequent co-authors are Samuel A. Bozzette, MD, PhD, John H. Chiu, MD and Stanley Casimer Deresinski, MD.

CMS Open Payments shows 151 general payments to Dr. Nussbaum from 15 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 51% of the total. Gilead Sciences, Inc. paid the most, $3,735.

Dmand AI lists 1 award for Dr. Nussbaum.

Dr. Nussbaum graduated from Universidad Autonoma de Guadalajara in 1981. Dr. Nussbaum is a member of ACP.

Dr. Nussbaum is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, LA Care and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.